
A significant proportion of patients seen by dermatologists have skin disease complicated by a psychiatric condition. These conditions often give rise to social, legal, and ethical concerns which impede the proper treatment of these patients, commonly involving the prescription of anti-psychotics for non-psychotic indications. This paper clarifies the social, legal, and ethical matters which frustrate the treatment and recovery of patients from their complex psycho-dermatologic disease. Specifically, this paper addresses the ethical and legal issues associated with prescribing anti-psychotics for non-psychotic indications. The presented data shows that the internationally prevalent medical practice of prescribing anti-psychotics for non-psychotic indications is not only ethical and legal, but also an essential treatment modality in the field of dermatology.
Adult, Mental Disorders, Prevalence, Humans, Bioethics, Child, Drug Approval, Skin Diseases, United States, Antipsychotic Agents
Adult, Mental Disorders, Prevalence, Humans, Bioethics, Child, Drug Approval, Skin Diseases, United States, Antipsychotic Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
